Literature DB >> 14521154

Green tea epigallocatechin-3-gallate is an inhibitor of mammalian histidine decarboxylase.

C Rodríguez-Caso1, D Rodríguez-Agudo, F Sánchez-Jiménez, M A Medina.   

Abstract

(-)-epigallocatechin-3-gallate, an antiproliferative and antiangiogenic component of green tea, has been reported to inhibit dopa decarboxylase. In this report,we show that this compound also inhibits histidine decarboxylase, the enzymic activity responsible for histamine biosynthesis. This inhibition was proved by a double approach, activity measurements and UV-Vis spectra of enzyme-bound pyridoxal-5'-phosphate. At 0.1 mM (-)-epi-gallocatechin-3-gallate, histidine decarboxylase activity was inhibited by more than 60% and the typical spectrum of the internal aldimine form shifted to a stable major maximum at 345 nm, suggesting that the compound causes a stable change in the structure of the holoenzyme. Since histamine release is one of the primary events in many inflammatory responses, a new potential application of (-)-epigallocatechin-3-gallate in prevention or treatment of inflammatory processes is suggested by these data.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521154     DOI: 10.1007/s00018-003-3135-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  12 in total

Review 1.  Structural features of mammalian histidine decarboxylase reveal the basis for specific inhibition.

Authors:  A A Moya-García; A Pino-Angeles; R Gil-Redondo; A Morreale; F Sánchez-Jiménez
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 2.  Targeting of histamine producing cells by EGCG: a green dart against inflammation?

Authors:  Esther Melgarejo; Miguel Angel Medina; Francisca Sánchez-Jiménez; José Luis Urdiales
Journal:  J Physiol Biochem       Date:  2010-07-22       Impact factor: 4.158

3.  Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase.

Authors:  Hirofumi Komori; Yoko Nitta; Hiroshi Ueno; Yoshiki Higuchi
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

4.  Ameliorative Effect of a Neoteric Regimen of Catechin plus Cetirizine on Ovalbumin-Induced Allergic Rhinitis in Rats.

Authors:  Mohamed A Morsy; Snehal S Patel; Anita Bakrania; Mahmoud Kandeel; Anroop B Nair; Jigar N Shah; Sabah H Akrawi; Mahmoud El-Daly
Journal:  Life (Basel)       Date:  2022-05-31

5.  The C-terminus of rat L-histidine decarboxylase specifically inhibits enzymic activity and disrupts pyridoxal phosphate-dependent interactions with L-histidine substrate analogues.

Authors:  John V Fleming; Ignacio Fajardo; Michael R Langlois; Francisca Sánchez-Jiménez; Timothy C Wang
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

6.  Mapping of catalytically important residues in the rat L-histidine decarboxylase enzyme using bioinformatic and site-directed mutagenesis approaches.

Authors:  John V Fleming; Francisca Sánchez-Jiménez; Aurelio A Moya-García; Michael R Langlois; Timothy C Wang
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

7.  Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.

Authors:  Esther Melgarejo; Miguel Angel Medina; Francisca Sánchez-Jiménez; José Luis Urdiales
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

8.  Role of green tea as an antioxidant in periodontal disease: The Asian paradox.

Authors:  Babitha Nugala; Ambalavanan Namasi; Pamela Emmadi; P Mohana Krishna
Journal:  J Indian Soc Periodontol       Date:  2012-07

9.  L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin.

Authors:  Timothy Clair; Eunjin Koh; Malgorzata Ptaszynska; Russell W Bandle; Lance A Liotta; Elliott Schiffmann; Mary L Stracke
Journal:  Lipids Health Dis       Date:  2005-02-28       Impact factor: 3.876

Review 10.  Molecular Regulation of Histamine Synthesis.

Authors:  Hua Huang; Yapeng Li; Jinyi Liang; Fred D Finkelman
Journal:  Front Immunol       Date:  2018-06-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.